BCRXBioCryst Pharmaceuticals, Inc.

$9.82

BCRX in its own filings

Nothing in BCRX's filing record raises a hard flag: no restatement, auditor change, late filing or delisting notice. That is the common case, not a distinction.

621

Events found in the filings · across 1,959 filings · the record starts in 1996

Hard flags
none

Hard flags

Most recent filing
2026-08-05

Most recent filing · Form 10-Q

Record starts
1996-06-25

Record starts · the earliest filing Ryufin has read for this name

Details
SEC comment-letter activity30 occurrences
2025-12-16

SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.

reading the record…